Table 3.
Forearm vascular conductance kinetic parameters to moderate handgrip exercise (15% maximal voluntary contraction)
| Group | G1, ml·dl−1·min−1·100 mmHg−1 | TD, s | Τ, s | MRT, s | r2 |
|---|---|---|---|---|---|
| SDF | |||||
| Control | 20.7 ± 2.5 | 2.5 ± 1.5 | 29.4 ± 7.2 | 31.7 ± 7.0 | 0.81 ± 0.03 |
| Drug | 21.9 ± 3.1 | 4.9 ± 2.0 | 27.6 ± 5.6 | 32.5 ± 3.7 | 0.80 ± 0.05 |
| l-NMMA | |||||
| Control | 15.1 ± 1.6 | 3.3 ± 3.5 | 18.7 ± 5.0 | 22.0 ± 4.8 | 0.73 ± 0.04 |
| Drug | 12.4 ± 0.9 | 3.8 ± 1.8 | 35.0 ± 6.7* | 39.5 ± 5.8* | 0.75 ± 0.03 |
| SDF + l-NMMA | |||||
| Control | 23.8 ± 3.3 | 4.1 ± 2.6 | 40.9 ± 9.6 | 45.1 ± 8.3 | 0.81 ± 0.03 |
| Drug | 23.3 ± 6.0 | 5.0 ± 2.3 | 44.4 ± 12.5 | 49.3 ± 11.3 | 0.83 ± 0.04 |
Data are reported as means ± SE.
*
P < 0.05, control vs. drug.
Note: G1 drug vs. control in l-NMMA group, P = 0.08.